Cardiovascular Drugs — MCQs

Cardiovascular Drugs Indian Medical PG Practice Questions and MCQs

Question 201: All of the following statements about Ranolazine are true, except?

A. Piperazine derived antianginal agent.
B. May be used as first line agent in chronic angina.
C. May improve glycemic control.
D. Hypotension is an established adverse effect. (Correct Answer)

Explanation: **Explanation:** **Ranolazine** is a novel antianginal agent with a unique mechanism of action. The correct answer is **D** because, unlike traditional antianginals (Nitrates, Beta-blockers, CCBs), **Ranolazine does not significantly affect heart rate or blood pressure.** Therefore, hypotension is not an established adverse effect. **Breakdown of Options:** * **Option A (True):** Ranolazine is chemically a **piperazine derivative**. It works by inhibiting the **late inward sodium current ($I_{Na}$)** in myocardial cells. This prevents calcium overload via the $Na^+/Ca^{2+}$ exchanger, improving diastolic relaxation and subendocardial perfusion without altering hemodynamics. * **Option B (True):** According to recent guidelines, Ranolazine is approved as a **first-line agent** for chronic stable angina, either as monotherapy or in combination with other drugs. * **Option C (True):** Clinical trials (like CARISA and MERLIN-TIMI 36) have shown that Ranolazine can **reduce HbA1c levels** in diabetic patients, making it a preferred choice for anginal patients with comorbid Diabetes Mellitus. **High-Yield Clinical Pearls for NEET-PG:** * **ECG Change:** Ranolazine causes **dose-dependent QT interval prolongation** (via inhibition of $I_{Kr}$), yet it paradoxically has a low risk of Torsades de Pointes. * **Metabolism:** It is primarily metabolized by **CYP3A4**; hence, it is contraindicated with potent inhibitors like Ketoconazole or Clarithromycin. * **Side Effects:** Most common side effects include dizziness, headache, constipation, and nausea. * **Key Benefit:** It is the drug of choice for angina patients who have low baseline blood pressure or heart rate, as it does not lower them further.

Question 202: Which drug is contraindicated in severe hypertriglyceridemia?

A. Fibrates
B. Simvastatin
C. Cholestyramine
D. Niacin (Correct Answer)

Explanation: **Explanation:** The correct answer is **Niacin (Nicotinic Acid)**. While Niacin is effective at lowering triglycerides, it is historically contraindicated or used with extreme caution in patients with severe hypertriglyceridemia who also have a history of **peptic ulcer disease, gout, or uncontrolled diabetes**, as it can exacerbate these conditions. However, in the context of standard pharmacological contraindications for lipid-lowering agents, **Cholestyramine (Bile Acid Sequestrants)** is the more classic "contraindication" for high triglycerides because it can actually **increase** triglyceride levels. *Note: There appears to be a discrepancy in the provided key. In standard medical teaching (and most NEET-PG sources), Bile Acid Sequestrants are contraindicated in hypertriglyceridemia, whereas Niacin is a primary treatment for it. If the key insists on Niacin, it is likely referring to its side-effect profile (hyperglycemia/hyperuricemia).* **Analysis of Options:** * **A. Fibrates:** These are the **drugs of choice** for severe hypertriglyceridemia. They activate PPAR-α, increasing LPL activity to clear VLDL. * **B. Simvastatin:** Statins are first-line for LDL lowering but also provide moderate triglyceride reduction. They are not contraindicated. * **C. Cholestyramine:** This drug inhibits bile acid reabsorption. A compensatory increase in hepatic cholesterol synthesis leads to a **rise in VLDL production**, which can worsen hypertriglyceridemia or trigger pancreatitis. * **D. Niacin:** It inhibits hormone-sensitive lipase in adipose tissue, reducing VLDL synthesis. It is a potent TG-lowering agent but is contraindicated in active peptic ulcer or liver disease. **High-Yield NEET-PG Pearls:** 1. **Drug of Choice for Hypertriglyceridemia:** Fibrates (e.g., Fenofibrate). 2. **Bile Acid Sequestrants (BAS):** Avoid if TG >300 mg/dL; absolute contraindication if TG >400 mg/dL due to risk of hypertriglyceridemic pancreatitis. 3. **Niacin Side Effects:** "Niacin Flush" (mediated by Prostaglandin D2; prevented by Aspirin), Hyperuricemia (Gout), and Hyperglycemia. 4. **Statin + Fibrate:** Increases risk of myopathy/rhabdomyolysis (Fenofibrate is preferred over Gemfibrozil when combining).

Question 203: Nesiritide is broken down by which enzyme?

A. Endopeptidase (Correct Answer)
B. Angiotensin converting enzyme
C. Vasopeptidase
D. Amidase

Explanation: **Explanation:** **Nesiritide** is a recombinant form of human **B-type Natriuretic Peptide (BNP)**. It is used in the management of acutely decompensated heart failure to reduce pulmonary capillary wedge pressure and improve dyspnea through its potent vasodilatory and natriuretic effects. 1. **Why Endopeptidase is correct:** Nesiritide, being a peptide, is primarily cleared from the circulation via two mechanisms: binding to natriuretic peptide receptors (NPR-C) followed by cellular internalization, and enzymatic degradation. The specific enzyme responsible for its proteolytic cleavage is **Neutral Endopeptidase (NEP)**, also known as **Neprilysin**. This enzyme breaks the peptide bonds of various endogenous vasoactive peptides, including BNP, ANP, and bradykinin. 2. **Why the other options are incorrect:** * **Angiotensin-converting enzyme (ACE):** While ACE is a peptidyl dipeptidase, its primary role is converting Angiotensin I to Angiotensin II and inactivating bradykinin. It does not play a significant role in the metabolism of BNP. * **Vasopeptidase:** This is not a single enzyme but a class of drugs (e.g., Omapatrilat) that inhibits both ACE and Neutral Endopeptidase. * **Amidase:** These enzymes catalyze the hydrolysis of an amide or peptide bond but are typically associated with the metabolism of drugs like lidocaine or certain prodrugs, not the physiological degradation of natriuretic peptides. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Nesiritide increases intracellular **cGMP**, leading to smooth muscle relaxation. * **Clinical Use:** Used in **Acute Decompensated Heart Failure (ADHF)** with dyspnea at rest. * **Major Side Effect:** Dose-related **hypotension** is the most common adverse effect. * **Related Drug:** **Sacubitril** is a Neprilysin inhibitor used in HFrEF (combined with Valsartan as ARNI) to prevent the breakdown of endogenous BNP.

Question 204: Which of the following beta-blockers has membrane stabilizing action?

A. Nadolol
B. Atenolol
C. Propranolol (Correct Answer)
D. Nebivolol

Explanation: **Explanation:** **Membrane Stabilizing Activity (MSA)**, also known as a "quinidine-like effect" or local anesthetic activity, refers to the ability of certain beta-blockers to inhibit the initiation and propagation of action potentials by blocking voltage-gated sodium channels. 1. **Why Propranolol is Correct:** **Propranolol** is the prototypical non-selective beta-blocker with significant MSA. At high concentrations, it reduces the rate of rise of the cardiac action potential (Phase 0). While this property is rarely clinically relevant at standard doses, it becomes highly significant in **toxicology** (overdose), leading to QRS widening and arrhythmias. Other drugs with MSA include Pindolol, Acebutolol, and Metoprolol (weak). 2. **Analysis of Incorrect Options:** * **Nadolol:** A long-acting, non-selective beta-blocker that lacks MSA and has low lipid solubility. * **Atenolol:** A cardioselective ($\beta_1$) blocker that is hydrophilic and lacks MSA. It is primarily excreted unchanged by the kidneys. * **Nebivolol:** A highly selective $\beta_1$ blocker that also promotes vasodilation via **Nitric Oxide (NO)** release. It does not possess MSA. **High-Yield Clinical Pearls for NEET-PG:** * **Lipid Solubility:** Propranolol is highly lipophilic, allowing it to cross the blood-brain barrier (useful for tremors and prophylaxis of migraine) but also causing CNS side effects like vivid dreams. * **Intrinsic Sympathomimetic Activity (ISA):** Remember **Pindolol** and **Acebutolol** for having partial agonist activity (useful in patients with bradycardia). * **Water Soluble Beta-blockers:** Atenolol and Nadolol (mnemonic: **A**ny **N**ew **S**oluble = Atenolol, Nadolol, Sotalol). * **Beta-blocker with longest half-life:** Nadolol; **Shortest half-life:** Esmolol (metabolized by RBC esterases).

Question 205: Which of the following drugs does not cause postural hypotension?

A. Prazosin
B. Phentolamine
C. Levodopa
D. ACE inhibitor (Correct Answer)

Explanation: **Explanation:** Postural (orthostatic) hypotension occurs when the body fails to maintain blood pressure during a change in position, usually due to the inhibition of the sympathetic baroreceptor reflex or significant volume depletion. **Why ACE Inhibitors are the correct answer:** ACE inhibitors (e.g., Enalapril, Lisinopril) primarily act by inhibiting the conversion of Angiotensin I to Angiotensin II. While they cause systemic vasodilation, they **do not interfere with the sympathetic baroreceptor reflex**. Therefore, the compensatory tachycardia and vasoconstriction required to maintain BP upon standing remain intact. While "first-dose hypotension" can occur with ACE inhibitors (especially in salt-depleted patients), true persistent postural hypotension is not a characteristic side effect. **Analysis of Incorrect Options:** * **Prazosin:** A selective alpha-1 blocker. It is notorious for the **"first-dose phenomenon,"** causing severe postural hypotension and syncope by preventing sympathetic-mediated vasoconstriction in the lower limbs. * **Phentolamine:** A non-selective alpha blocker. By blocking alpha-1 and alpha-2 receptors, it causes profound vasodilation and prevents the baroreceptor reflex from constricting blood vessels, leading to significant orthostatic hypotension. * **Levodopa:** Used in Parkinson’s disease, it causes postural hypotension through both central mechanisms and peripheral conversion to dopamine, which acts on vascular receptors to cause vasodilation. **High-Yield Clinical Pearls for NEET-PG:** * **Drugs causing Postural Hypotension:** Alpha-blockers, Diuretics (volume depletion), TCAs, Phenothiazines, Nitrates, and Levodopa. * **ACE Inhibitor Side Effects (Mnemonic: CAPTOPRIL):** **C**ough (dry), **A**ngioedema, **P**otassium excess (Hyperkalemia), **T**aste changes, **O**rthostatic hypotension (rare/first dose only), **P**regnancy contraindication, **R**enal artery stenosis contraindication, **I**tch (rash), **L**eukopenia. * **Drug of choice** for treating orthostatic hypotension: **Midodrine** (alpha-1 agonist) or **Fludrocortisone**.

Question 206: Which of the following drugs is capable of maintaining blood levels for 24 hours after a single administration but has useful antianginal effects lasting only about 10 hours?

A. Amyl nitrite
B. Isosorbide mononitrate
C. Nitroglycerine (sublingual)
D. Nitroglycerine (transdermal) (Correct Answer)

Explanation: **Explanation:** The correct answer is **Nitroglycerine (transdermal)**. This question tests the concept of **nitrate tolerance**, a critical pharmacological phenomenon in cardiovascular medicine. **1. Why Transdermal Nitroglycerine is correct:** Transdermal patches are designed for sustained release, maintaining measurable drug levels in the blood for 24 hours. However, continuous exposure to nitrates leads to **tachyphylaxis (tolerance)**, primarily due to the depletion of free sulfhydryl groups and increased oxidative stress, which prevents the conversion of the drug into Nitric Oxide (NO). Consequently, while the drug remains in the blood, its antianginal efficacy diminishes significantly after **8–10 hours**. To prevent this, a "nitrate-free interval" of 10–12 hours (usually at night) is clinically mandated. **2. Why other options are incorrect:** * **Amyl nitrite:** An inhalational nitrate with an ultra-short duration of action (3–5 minutes). It is used for immediate relief or cyanide poisoning, not for 24-hour maintenance. * **Isosorbide mononitrate:** While it has a long half-life and high bioavailability, its standard formulations do not exhibit the specific 24-hour blood level vs. 10-hour effect discrepancy as classically described for the transdermal patch in the context of tolerance. * **Nitroglycerine (sublingual):** Used for acute anginal attacks. It has a rapid onset (1–3 mins) and a very short duration of action (20–30 mins) due to significant first-pass metabolism if swallowed. **Clinical Pearls for NEET-PG:** * **Nitrate-free interval:** Essential to restore the sensitivity of soluble guanylyl cyclase; typically 10–12 hours daily. * **Monday Disease:** Workers in dynamite factories developed tolerance during the week but lost it over the weekend, leading to severe headaches (vasodilation) upon returning to work on Mondays. * **Drug Interaction:** Never co-administer nitrates with **Sildenafil** (PDE-5 inhibitors) as it can cause life-threatening hypotension.

Question 207: What is the treatment of choice for congestive heart failure with hypertension?

A. ACE inhibitors (Correct Answer)
B. Alpha-blockers
C. Calcium channel blockers
D. Nitrates

Explanation: **Explanation:** **ACE inhibitors (ACEIs)** are the treatment of choice for patients with coexisting congestive heart failure (CHF) and hypertension [1]. The underlying medical concept is their ability to provide **balanced vasodilation** (reducing both preload and afterload) and, more importantly, to inhibit the **Renin-Angiotensin-Aldosterone System (RAAS)** [2]. By blocking Angiotensin II, ACEIs prevent cardiac remodeling and fibrosis, which are key drivers of heart failure progression [2]. They are one of the few drug classes proven to **reduce mortality** in CHF [1]. **Why other options are incorrect:** * **Alpha-blockers:** These are not first-line for CHF. While they lower blood pressure, they can cause reflex tachycardia and fluid retention, potentially worsening heart failure symptoms. * **Calcium Channel Blockers (CCBs):** Non-dihydropyridines (Verapamil/Diltiazem) are contraindicated in CHF due to their negative inotropic effects. While Amlodipine is safe, it does not provide the mortality benefits seen with ACEIs. * **Nitrates:** These are primarily venodilators (reducing preload) [3]. While useful in acute heart failure or in combination with Hydralazine (especially in specific populations), they are not the primary first-line monotherapy for managing chronic CHF with hypertension [3]. **High-Yield Clinical Pearls for NEET-PG:** * **First-line triad for HFrEF:** ACEIs (or ARBs/ARNIs), Beta-blockers, and Aldosterone antagonists [1]. * **Side Effects:** Watch for **dry cough** (due to bradykinin accumulation) and **angioedema**. If a cough develops, switch the patient to an ARB (Losartan). * **Contraindications:** ACEIs are strictly contraindicated in **pregnancy** (teratogenic) and **bilateral renal artery stenosis**.

Question 208: First-dose hypotension is caused by which of the following drugs?

A. Prazosin (Correct Answer)
B. Clonidine
C. Sodium nitroprusside
D. Propranolol

Explanation: **Explanation:** **Prazosin** is the correct answer because it is a selective **alpha-1 (α1) adrenergic blocker**. It causes significant peripheral vasodilation in both arterioles and veins. The "first-dose effect" occurs because the initial dose can cause a sudden, precipitous drop in blood pressure, leading to orthostatic hypotension and syncope. This happens because the drug inhibits the compensatory vasoconstriction required when a patient moves from a supine to a standing position. **Analysis of Incorrect Options:** * **Clonidine:** An alpha-2 agonist that acts centrally to decrease sympathetic outflow. While it lowers BP, it is more notorious for **rebound hypertension** upon sudden withdrawal rather than first-dose hypotension. * **Sodium Nitroprusside:** A potent parenteral vasodilator used in hypertensive emergencies. While it causes rapid hypotension, it is administered via titrated IV infusion in a controlled setting, not as an oral "first dose" phenomenon. * **Propranolol:** A non-selective beta-blocker. It reduces cardiac output and renin release. It does not typically cause acute postural hypotension; in fact, it can sometimes cause initial peripheral vasoconstriction due to unopposed alpha activity. **High-Yield Clinical Pearls for NEET-PG:** * **Prevention:** To minimize the first-dose effect, the initial dose of Prazosin should be small (1 mg) and administered **at bedtime** ("Bedtime dose"). * **Other Drugs:** Other alpha-blockers like Terazosin and Doxazosin also exhibit this effect. * **Indication:** Apart from hypertension, Prazosin is used in **Benign Prostatic Hyperplasia (BPH)** to relax the bladder neck and in **Raynaud’s phenomenon**.

Question 209: What is the primary role of nitrates in congestive cardiac failure?

A. Direct inotropic action
B. Decrease preload (Correct Answer)
C. Decrease afterload
D. Coronary vasodilatation

Explanation: **Explanation:** In the management of Congestive Cardiac Failure (CCF), the primary therapeutic goal of nitrates is to reduce the workload on the failing heart. **Why "Decrease Preload" is correct:** Nitrates (e.g., Nitroglycerin, Isosorbide dinitrate) act primarily as **venodilators**. At therapeutic doses, they increase venous capacitance, leading to peripheral pooling of blood [1]. This reduces venous return to the heart, thereby **decreasing the Left Ventricular End-Diastolic Pressure (LVEDP) or Preload** [4]. By reducing preload, nitrates decrease ventricular wall tension and myocardial oxygen demand, providing symptomatic relief, especially in cases of pulmonary congestion [2]. **Analysis of Incorrect Options:** * **A. Direct inotropic action:** Nitrates have no effect on myocardial contractility [2]. Inotropic agents like Digoxin or Dobutamine are used for this purpose. * **C. Decrease afterload:** While high-dose intravenous nitrates can cause some arterial dilation (reducing afterload), their **primary** and most significant effect in CCF is venodilation (preload reduction) [1]. Pure afterload reducers include Hydralazine or ACE inhibitors. * **D. Coronary vasodilatation:** Although nitrates do dilate coronary arteries (useful in Angina), this is not their primary role in the pathophysiology of *heart failure* management [3]. **NEET-PG High-Yield Pearls:** * **Mechanism:** Nitrates are prodrugs that release **Nitric Oxide (NO)**, which stimulates **guanylyl cyclase**, increasing **cGMP** and leading to dephosphorylation of myosin light chains (relaxation) [3]. * **Drug of Choice:** IV Nitroglycerin is a preferred agent for **Acute Left Ventricular Failure** with pulmonary edema [1]. * **Nitrate Tolerance:** Continuous use leads to "tachyphylaxis" due to depletion of free sulfhydryl (-SH) groups; a 10–12 hour "nitrate-free interval" is essential. * **Combination Therapy:** The combination of **Hydralazine (afterload reducer) + Isosorbide dinitrate (preload reducer)** has been shown to improve mortality in specific populations (e.g., BiDil in African-Americans) [5].

Question 210: Digoxin induced arrhythmias are treated by all the following except?

A. Lidocaine
B. Phenytoin
C. Atropine
D. Quinidine (Correct Answer)

Explanation: **Explanation:** **Quinidine (Option D)** is the correct answer because it is strictly **contraindicated** in digoxin toxicity. Quinidine increases plasma digoxin levels by displacing it from tissue binding sites and reducing its renal clearance. Furthermore, both drugs can cause additive depression of the AV node, potentially worsening heart block. **Why other options are used:** * **Lidocaine (Option A):** This is the drug of choice for digoxin-induced ventricular arrhythmias (PVCs, ventricular tachycardia). It suppresses ventricular automaticity without significantly affecting AV conduction. * **Phenytoin (Option B):** Specifically useful for digoxin-induced atrial tachyarrhythmias with AV block. It suppresses abnormal automaticity while simultaneously improving AV conduction. * **Atropine (Option C):** Used to treat digoxin-induced symptomatic bradycardia or high-grade AV block by blocking the excessive vagal (parasympathetic) tone caused by digitalis. **Clinical Pearls for NEET-PG:** 1. **Most common arrhythmia:** Ventricular Bigeminy (PVCs). 2. **Most characteristic arrhythmia:** Atrial Tachycardia with variable AV block. 3. **Electrolyte imbalances:** Hypokalemia, hypomagnesemia, and hypercalcemia predispose to toxicity. However, **Hyperkalemia** is a marker of severe acute toxicity (due to Na+/K+ ATPase inhibition). 4. **Specific Antidote:** Digoxin Immune Fab (Digibind) is the definitive treatment for life-threatening toxicity. 5. **Drugs increasing Digoxin levels:** Quinidine, Verapamil, Amiodarone, and Erythromycin.

Practice by Chapter

Antihypertensive Agents

Practice Questions

Drugs for Heart Failure

Practice Questions

Antiarrhythmic Drugs

Practice Questions

Antianginal Agents

Practice Questions

Lipid-Lowering Drugs

Practice Questions

Anticoagulants and Antiplatelet Drugs

Practice Questions

Thrombolytic Agents

Practice Questions

Drugs Used in Pulmonary Hypertension

Practice Questions

Drugs Used in Shock

Practice Questions

Cardiovascular Effects of Non-Cardiovascular Drugs

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free